Skip to content
Home » Archives for frederic.lesage@e-mhicc.org » Page 2

frederic.lesage@e-mhicc.org

Jean-Claude Tardif is the winner of the Desmond Julian Prize from the European Heart Journal

    Jean-Claude Tardif is the winner of the Desmond Julian Prize from the European Heart Journal (This article is available exclusively in French) Le Dr Jean-Claude Tardif, directeur du Centre de recherche de l’Institut de cardiologie de Montréal et professeur titulaire de médecine à l’Université de Montréal,… Read More »Jean-Claude Tardif is the winner of the Desmond Julian Prize from the European Heart Journal

    Article by Karim Aly, CEO of our partner Noze – AI Powered Breath Analysis for Early Disease Screening & Diagnostics

      Article by Karim Aly, CEO of our partner Noze – AI Powered Breath Analysis for Early Disease Screening & Diagnostics Most people would likely agree that the healthcare industry is in need of a good shakeup, particularly in the domains of disease screening and diagnostics.… Read More »Article by Karim Aly, CEO of our partner Noze – AI Powered Breath Analysis for Early Disease Screening & Diagnostics

      Blog – Dr. Marie-Pierre Dubé, director of the MHI’s Pharmacogenomics Centre, a project partner, talks about precision medicine.

        Blog – Dr. Marie-Pierre Dubé, director of the MHI’s Pharmacogenomics Centre, a project partner, talks about precision medicine. A real math and biology whiz, Dr. Dubé first developed a keen interest in genetics during university. “I fell in love with genetics. I saw it as… Read More »Blog – Dr. Marie-Pierre Dubé, director of the MHI’s Pharmacogenomics Centre, a project partner, talks about precision medicine.

        A study from the Montreal Heart Institute, led by Dr. Tardif, principal investigator of our project, is behind the approval of colchicine in the United States.

          A study from the Montreal Heart Institute, led by Dr. Tardif, principal investigator of our project, is behind the approval of colchicine in the United States. THIS ARTICLE IS AVAILABLE EXCLUSIVELY IN FRENCH La FDA des États-Unis a approuvé la semaine dernière la colchicine à… Read More »A study from the Montreal Heart Institute, led by Dr. Tardif, principal investigator of our project, is behind the approval of colchicine in the United States.

          Perceiv AI Joins Johnson & Johnson Innovation–JLABS Global Network to Accelerate Precision Medicine Platform Development 

            Perceiv AI Joins Johnson & Johnson Innovation–JLABS Global Network to Accelerate Precision Medicine Platform Development  Perceiv AI, an AI-driven precision medicine company, today announced that it has joined Johnson & Johnson Innovation–JLABS, a premier life science incubator program. Perceiv AI will gain access to a… Read More »Perceiv AI Joins Johnson & Johnson Innovation–JLABS Global Network to Accelerate Precision Medicine Platform Development 

            Government of Canada supports Omnimed and its unique project in Quebec’s digital health sector

              Government of Canada supports Omnimed and its unique project in Quebec’s digital health sector Supporting innovative projects contributes to economic development in Quebec’s regions. That is why the Member of Parliament for Compton–Stanstead and Minister of Agriculture and Agri‑Food, the Honourable Marie‑Claude Bibeau, is today announcing, on… Read More »Government of Canada supports Omnimed and its unique project in Quebec’s digital health sector

              Our Partner Kelvin Zero Released a White Paper on Digital Solutions to Protect Patient Health Data

                Our Partner Kelvin Zero Released a White Paper on Digital Solutions to Protect Patient Health Data The human lifespan has doubled since 1800, largely thanks to healthcare improvements – the engine of our society’s well-being. Beyond hospitals, doctors, nurses, and medicine, protected health information (PHI)… Read More »Our Partner Kelvin Zero Released a White Paper on Digital Solutions to Protect Patient Health Data